Innote (688253.SH) announced semi-annual results, net profit of 31.12 million yuan to mother, a year-on-year decrease of 75.12%

According to Zhitong Finance App News, Innote (688253.SH) disclosed the 2026 semi-annual report. During the reporting period, the company achieved operating income of 141 million yuan, a year-on-year decrease of 49.09%; net profit attributable to shareholders of listed companies was 31.12 million yuan, a year-on-year decrease of 75.12%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 1.64 million yuan, a year-on-year decrease of 82.31%; and basic earnings per share were 0.23 yuan.

The company's operating income and gross margin declined in the first half of the year due to factors such as changes in the intensity of respiratory disease prevalence and increased competition in the in vitro diagnosis market, leading to a year-on-year decline in financial indicators related to profit and cash flow.